Immunomedics Inc.

Immunomedics Shares Double as Promising Results Halt Breast Cancer Drug Study

Immunomedics Inc’s shares (IMMU) more than doubled after the biotech company said a study of its breast cancer drug was halted early on “compelling evidence …

Sharon Wrobel — April 6, 2020, 2:58 PM EDT

Joel Greenblatt Pulls the Trigger on Kite Pharma Inc (KITE), Immunomedics, Inc. (IMMU) and Valeant Pharmaceuticals Intl Inc (VRX)

Greenblatt’s Gotham Management Turns Bullish on These 3 Biotech Stocks

Harriet Lefton Harriet Lefton — August 29, 2017, 8:59 AM EDT

Valeant Pharmaceuticals Intl Inc’s Glaucoma Drug Could Be A Blockbuster, Immunomedics, Inc.’s Breast Cancer Drug Potential Significantly Undervalued

Valeant’s Good News- Manufacturing Qualms Could Be Put at Rest Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has revealed the FDA’s confirmed intention to issue …

Julie Lamb Julie Lamb — August 17, 2017, 9:10 AM EDT

J.P. Morgan Comments on Immunomedics, Inc. (IMMU) and Seattle Genetics (SGEN) Deal

This morning, Immunomedics, Inc. (NASDAQ:IMMU) and Seattle Genetics, Inc.

Jason Cohen Jason Cohen — February 10, 2017, 4:02 PM EDT

Two Biotech Stocks Analysts Are Talking About: Immunomedics, Inc. (IMMU), Ocular Therapeutix Inc (OCUL)

Immunomedics, Inc. Immunomedics, Inc.

Ben Mahaney, Editor — February 10, 2017, 11:25 AM EDT

Company Update (NASDAQ:IMMU): Here’s Why Immunomedics, Inc. Shares Are Falling 27%

Immunomedics, Inc. (NASDAQ:IMMU) announced that it has priced an underwritten offering of 10,000,000 shares of common stock and warrants to purchase up to …

Corey Williams — October 5, 2016, 11:11 AM EDT

Analysts Weigh In On Two Falling Biotechs: Adamis Pharmaceuticals Corp (ADMP), Immunomedics, Inc. (IMMU)

Analysts are weighing in on biotech firms Adamis Pharmaceuticals Corp (NASDAQ:ADMP) and Immunomedics, Inc. (NASDAQ:IMMU), as shares of both companies fell sharply today due to …

Jason Cohen Jason Cohen — June 6, 2016, 1:19 PM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts